Japan ensures consistency among drug quality auditors through standardized training programs, strict regulatory guidelines, and regular audits by the Pharmaceuticals and Medical Devices Agency (PMDA). The use of harmonized procedures and continuous professional development further supports uniformity, while collaboration with international bodies ensures alignment with global standards.
